Systems, devices and methods for monitoring efficiency of pacing

• US 8,538,521 B2
• Filed: 08/25/2011
• Issued: 09/17/2013
• Est. Priority Date: 12/20/2004
• Status: Expired due to Fees

• Current Assignee: Newstim, Inc.
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Zhu, Qingsheng, Ortega, Daniel Felipe
• Primary Examiner(s): Gedeon, Brian T
• Application Number:
  US13/217,776
• Publication Number:
  US 20110307026A1
• Time in Patent Office: 754 Days
• Field of Search: 607/2, 607/4, 607/5, 607/9, 607/25
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36592 controlled by the heart rate variability

Abstract

Various systems, methods, devices and arrangements are implemented for use in pacing of the heart. One implementation is directed to methods and systems for determining a pacing location in the right ventricle of a heart and near the His bundle. A pacing signal is delivered to the location in the right ventricle. The pacing signal produces a capture of a left ventricle. Properties of the capture are monitored. Results of the monitored capture are used to assess the effectiveness of the delivered pacing signal as a function of heart function. The heart function can be, for example, at least one of a QRS width, fractionation and a timing of electrical stimulation of a late activation site of a left ventricle relative to the QRS.

Claims

1. An apparatus comprising:

a monitoring circuit configured to monitor a left ventricular contraction elicited at least partially in response to an electrostimulation delivered from a location in a right ventricle of the heart at or near a His bundle, the electrostimulation comprising two at least partially overlapping opposite polarity waveforms; and

a processor circuit configured to;

determine an efficacy of the delivered electrostimulation using information provided by the monitoring circuit obtained during the left ventricular contraction about at least one of;

a QRS width, an electrogram fractionation, a pressure generated by the heart, or a timing activation of a late activation site of the left ventricle; and

adjust an electrostimulation parameter for subsequent electrostimulation using information about the efficacy.

2. The apparatus of claim 1, wherein the processor circuit is configured to determine the efficacy using information about the left ventricular contraction and a second left ventricular contraction elicited via respective electrostimulation delivered at different sites.

3. The apparatus of claim 1, wherein the processor circuit is configured to determine the efficacy of delivered electrostimulation in response to electrostimulation delivered in a septal region of the right ventricle at or near the His bundle.

4. The apparatus of claim 1, comprising a pulse generation circuit configured to generate the electrostimulation.

5. The apparatus of claim 4, wherein the monitoring circuit, the processor circuit, and the pulse generator circuit are included as a portion of an implantable assembly.

6. The apparatus of claim 5, further comprising an implantable lead assembly including a first electrode and a second electrode;

and

wherein the pulse generator circuit is configured to generate the electrostimulation comprising two at least partially overlapping opposite polarity waveforms including a first polarity waveform for delivery via the first electrode and a second polarity waveform for delivery via the second electrode.

7. The apparatus of claim 1, wherein determining the efficacy of the delivered electrostimulation includes determining a relative indication of information about a QRS width associated with the monitored contraction relative to an earlier monitored QRS width or a reference QRS width.

8. The apparatus of claim 1, wherein the processor is configured to determine the efficacy at least in part by the pressure generated by the heart.

9. The apparatus of claim 1, wherein the processor is configured to determine the efficacy at least in part by a timing of activation of a late activation site of the left ventricle.

10. The apparatus of claim 1, wherein the processor is configured to determine the efficacy at least in part by the electrogram fractionation.

11. The apparatus of claim 1, wherein the processor is configured to determine the efficacy at least in part by the QRS width.

12. A processor-readable medium including instructions that, when performed by a processor, cause the processor to:

monitor a left ventricular contraction elicited at least partially in response to an electrostimulation delivered from a location in a right ventricle of the heart at or near a His bundle, the electrostimulation comprising two at least partially overlapping opposite polarity waveforms;

determine an efficacy of the delivered electrostimulation using information provided by the monitoring operation about at least one of;

a QRS width, an electrogram fractionation, a pressure generated by the heart, or a timing of activation of a late activation site of the left ventricle; and

adjust an electrostimulation parameter for subsequent electrostimulation using information about the efficacy.

13. The processor-readable medium of claim 12, wherein the instructions that cause the processor to determine the efficacy of the delivered electrostimulation include instructions to determine the efficacy by using information about the left ventricular contraction and a second left ventricular contraction elicited via respective electrostimulation delivered at different sites.

14. The processor-readable medium of claim 13, wherein the instructions that cause the processor to determine the efficacy of the delivered electrostimulation include instructions to determine the efficacy of the delivered electrostimulation in response to electrostimulation delivered in a septal region of the right ventricle at or near the His bundle.

15. The processor-readable medium of claim 12, wherein the instructions include instructions that cause the processor to generate electrostimulation comprising two at least partially overlapping opposite polarity biphasic waveforms.

16. The processor-readable medium of claim 15, wherein the instructions that cause the processor to generate electrostimulation comprising two at least partially overlapping opposite polarity waveforms include:

generating electrostimulation comprising two at least partially overlapping opposite polarity waveforms including a first polarity waveform for delivery via a first electrode and a second polarity waveform for delivery via a second electrode.

17. The processor-readable medium of claim 12, wherein the instructions for determining the efficacy of the delivered electrostimulation include instructions to determine the efficacy by determining a relative indication of information about a QRS width associated with the monitored contraction relative to an earlier monitored QRS width or a reference QRS width.

18. The processor-readable medium of claim 12, wherein the instructions for determining the efficacy of the delivered electrostimulation include instructions to determine the efficacy at least in part by using the timing activation of a late activation site of the left ventricle.

19. The processor-readable medium of claim 12, wherein the instructions for determining the efficacy of the delivered electrostimulation include instructions to determine the efficacy at least in part by using the fractionation.

20. The processor-readable medium of claim 12, wherein the instructions for determining the efficacy of the delivered electrostimulation include instructions to determine the efficacy at least in part by using the QRS width.

21. The processor-readable medium of claim 12, wherein the instructions for determining the efficacy of the delivered electrostimulation include instructions to determine the efficacy at least in part by using the pressure generated by the heart.

22. A method comprising:

monitoring a left ventricular contraction elicited at least partially in response to an electrostimulation delivered from a location in a right ventricle of the heart at or near a His bundle, the electrostimulation comprising two at least partially overlapping opposite polarity waveforms;

determining an efficacy of the delivered electrostimulation using information provided by the monitoring operation about at least one of;

a QRS width, an electrogram fractionation, a pressure generated by the heart, or a timing of activation of a late activation site of the left ventricle; and

adjusting an electrostimulation parameter for subsequent electrostimulation using information about the efficacy.